
CAS 1628752-83-9
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
4 produits concernés.
Palbociclib-d8
CAS :Palbociclib-d8 (PD 0332991 D8) is the deuterated form of Palbociclib. Palbociclib is a CDK inhibitor that inhibits CDK4 and CDK6.Formule :C24H21D8N7O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :455.58Palbociclib-d8
CAS :Produit contrôléFormule :C24D8H21N7O2Couleur et forme :NeatMasse moléculaire :455.582Palbociclib-d8
CAS :Produit contrôlé<p>Palbociclib-d8 is a potential antineoplastic agent that inhibits the aromatase enzyme. It has been shown to inhibit the growth of breast cancer cells by blocking the synthesis of estrogen, which is required for tumor cell proliferation. Palbociclib-d8 binds to the aromatase enzyme and prevents the conversion of androgens into estrogens. This drug has also been shown to reduce tumor metastases in mice by inhibiting DNA replication and protein synthesis, leading to apoptosis. Palbociclib-d8 can be taken orally and has a favorable safety profile in animals; however, it is not yet approved for use in humans.</p>Formule :C24H21D8N7O2Degré de pureté :Min. 95%Masse moléculaire :455.58 g/mol



